Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EACR 2016 /
miRNA screening through nipple aspiration sampling

9th - 12th Jul 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.07.16
Views: 2261
Rating:

Dr Cathy Moelans - University Medical Center Utrecht, Utrecht, Netherlands

Dr Moelans talks to ecancertv at EACR 2016 about the feasibility of detecting microRNAs in nipple aspiration fluid (NAF) samples.

The study has shown that the aspiration procedure is associated with significantly lower discomfort rates than mammography and MRI.

For BRCA mutation carriers, the aim is to develop a NAF screening tool that may help these women decide on the timing of their prophylactic surgery, up to postponement or perhaps even avoidance.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation